Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells

Afroz R, Cao Y, Rostam MA, Ta H, Xu S, Zheng W, Osman N, Kamato D, Little PJ (2018) Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: implications for lipoprotein binding and atherosclerosis. Pharmacol Ther 187:88–97

Anggraeni VY, Emoto N, Yagi K, Mayasari DS, Nakayama K, Izumikawa T, Kitagawa H, Hirata K-I (2011) Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis. Biochem Biophys Res Commun 406:36–41

Ballinger ML, Nigro J, Frontanilla KV, Dart AM, Little PJ (2004) Regulation of glycosaminoglycan structure and atherogenesis. Cell Mol Life Sci 61:1296–1306

Ballinger ML, Osman N, Hashimura K, De Haan JB, Jandeleit-Dahm K, Allen T, Tannock LR, Rutledge JC, Little PJ (2010) Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 14:1408–1418

Barry-Lane PA, Patterson C, Van Der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS (2001) p47phox is required for atherosclerotic lesion progression in ApoE−/−mice. J Clin Investig 108:1513–1522

Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G (1999) Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 99:2883–2891

Burch ML, Yang SN, Ballinger ML, Getachew R, Osman N, Little PJ (2010) TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. Cell Mol Life Sci 67:2077–2090

Burch ML, Zheng W, Little PJ (2011) Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci 68:97–107

Choi YJ, Kim DH, Kim SJ, Kim J, Jeong SI, Chung CH, Yu KY, Kim SY (2014) Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P) H oxidase activation and Smad signaling in vivo and in vitro. Life Sci 108:94–103

Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D (2005) NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97:900–907

Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ (2008) Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 283:7844–7852

Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584

Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453–471

Ge A, Ma Y, Liu Y-N, Li Y-S, Gu H, Zhang J-X, Wang Q-X, Zeng X-N, Huang M (2016) Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways. Life Sci 153(1–8):1–8

Grande-Allen KJ, Osman N, Ballinger ML, Dadlani H, Marasco S, Little PJ (2007) Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease. Cardiovasc Res 76:19–28

Groth S, Schulze M, Kalthoff H, Fandrich F, Ungefroren H (2005) Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. J Biol Chem 280:33190–33199

Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211–217

Jiang W, Zhang Y, Wu H, Zhang X, Gan H, Sun J, Chen Q, Guo M, Zhang Z (2010) Role of cross-talk between the Smad2 and MAPK pathways in TGF-β1-induced collagen IV expression in mesangial cells. Int J Mol Med 26:571–576

Jiang F, Liu G-S, Dusting GJ, Chan EC (2014) NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. Redox Biol 2:267–272

Kamato D, Babaahmadi Rezaei H, Getachew R, Thach L, Guidone D, Osman N, Roufogalis B, Duke CC, Tran VH, Zheng W, Little PJ (2013a) (S)-[6]-Gingerol inhibits TGF-beta-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells. J Pharm Pharmacol 65:1026–1036

Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N (2013b) Transforming growth factor-beta signalling: role and consequences of Smad linker region phosphorylation. Cell Signal 25:2017–2024

Kamato D, Rostam MA, Piva TJ, Babaahmadi Rezaei H, Getachew R, Thach L, Bernard R, Zheng W, Little PJ, Osman N (2014) Transforming growth factor beta-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells. J Pharm Pharmacol 66:1722–1733

Kamato D, Thach L, Getachew R, Burch M, Hollenberg MD, Zheng W, Little PJ, Osman N (2016) Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes. Cell Signal 28:110–119

Kinkade K, Streeter J, Miller FJ (2013) Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci 14:17017–17028

Lassègue B, San Martín A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364–1390

Li F, Zeng B, Chai Y, Cai P, Fan C, Cheng T (2009) The linker region of Smad2 mediates TGF-β-dependent ERK2-induced collagen synthesis. Biochem Biophys Res Commun 386:289–293

Little PJ, Tannock L, Olin KL, Chait A, Wight TN (2002) Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol 22:55–60

Massague J (2003) Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev 17:2993–2997

Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810

Miller AA, De Silva TM, Judkins CP, Diep H, Drummond GR, Sobey CG (2010) Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia. Stroke 41:784–789

Rezaei HB, Kamato D, Ansari G, Osman N, Little PJ (2012) Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle. Clin Exp Pharmacol Physiol 39:661–667

Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh S-T, Lee HB (2005) Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16:667–675

Rostam MA, Kamato D, Piva TJ, Zheng W, Little PJ, Osman N (2016) The role of specific Smad linker region phosphorylation in TGF-beta mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle. Cell Signal 28:956–966

Rostam MA, Shajimoon A, Kamato D, Mitra P, Piva T, Getachew R, Cao Y, Zheng W, Osman N, Little PJ (2018) Flavopiridol inhibits TGF-beta-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2. J Pharmacol Exp Ther 365:156–164

Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ (2011) Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216:321–326

Silbert JE, Sugumaran G (2002) Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 54:177–186

Sirker A, Zhang M, Shah AM (2011) NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106:735–747

Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO (2011) Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J Signal Transduct 2011:792639

Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, Ten Dijke P, Heldin C-H (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 272:28107–28115

Talati N, Kamato D, Piva TJ, Little PJ, Osman N (2018) Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation. Cell Signal 47:37–43

Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005–L1028

Touyz RM, Cruzado M, Tabet F, Yao GY, Salomon S, Schiffrin EL (2003) Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81:159–167

Vejrazka M, Micek R, Stipek S (2005) Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta 1722:143–147

Wrighton KH, Lin X, Feng X-H (2009) Phospho-control of TGF-β superfamily signaling. Cell Res 19:8–20

Yang SN, Burch ML, Tannock LR, Evanko S, Osman N, Little PJ (2010) Transforming growth factor-beta regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes 2:233–242

Yang Y, Wang Z, Yang H, Wang L, Gillespie SR, Wolosin JM, Bernstein AM, Reinach PS (2013) TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop. PLoS One 8:e77300